Skip to content

MACE CDS Software Master Enrollment Protocol

MACE CDS Software Master Enrollment Protocol

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06257628
Enrollment
0
Registered
2024-02-14
Start date
2023-09-14
Completion date
2025-05-31
Last updated
2025-11-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Events

Keywords

Emergency Department, Major Adverse Cardiac Events

Brief summary

This protocol will collect real world EHR data to support the product development life cycle activities associated with developing the Major Adverse Cardiac Events (MACE) Clinical Decision Support (CDS) software. The data will also be utilized in subsequent clinical validation to support an FDA application and/or applications to other regulatory agencies as needed.

Detailed description

The primary objective is to develop a machine learning tool which predicts risk of 30-day MACE (major adverse cardiac event) risk stratification among patients visiting ED with suspicion of ACS (Acute Coronary Syndrome). The data will also be utilized in subsequent clinical validation. In addition to retrospective Electronic Health Record (EHR) data, Health Information Exchange (HIE) data and patient reported outcomes will be collected to capture 30-day MACE outcomes, as applicable.

Interventions

DEVICEIndex Event

Patients with at least one Beckman High Sensitivity Troponin test at the Emergency Department visit

Sponsors

Beckman Coulter, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
23 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All genders, races, ethnicities

Exclusion criteria

* ≤ 18 years old presenting to the ED and for clinical validation only, adults \< 22 years old

Design outcomes

Primary

MeasureTime frameDescription
Performance Characteristics NPV (Negative Predictive Value), Specificity and SensitivityWithin 30-days from the Emergency Department Visit with suspicion of ACS (Acute Coronary Syndrome)Clinical performance of MACE (Major Adverse Cardiac Events) CDS (Clinical Decision Support) tool to identify a patient's risk of for having a MACE (Major Adverse Cardiac Events) within 30 days, with both a single High-Sensitive Troponin and a second High-Sensitive Troponin (if applicable).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026